2023-05-12 05:18:00 ET
- MedinCell ( OTC:MDCLF ) prices its global offering for a final amount of €25.1M through an offering to French and international investors via a private placement and to retail investors in France.
-
Proceeds will be used for preclinical and clinical activities, formulation activities of new products, to expand and improve the laboratory in Montpellier, France, and for research, development of new technologies.
-
The global offering, for a total of €25.1M, was carried out via the issuance without shareholder's preferential subscription rights of 3.43M new shares, with a nominal value of 0.01 euros each.
For further details see:
MedinCell prices global offering and raises ~€25M